Dergiler / Çocuk Enfeksiyon Dergisi / 2021 / Cilt: 15 - Sayı: 1

COVID-19 Enfeksiyonu Sonrası Gelişen Antikorların Niteliği ve Koruyuculuk Süresi

Sayfa
66–63
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

TURAN, C., HACIMUSTAFAOĞLU, M. (2021). COVID-19 Enfeksiyonu Sonrası Gelişen Antikorların Niteliği ve Koruyuculuk Süresi. Çocuk Enfeksiyon Dergisi, Cilt: 15 - Sayı: 1, 66–63. https://ajindex.com/articles/413632

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Caliendo AM, Hanson KE, Hirsch MS, Bloom A. Coronavirus disease 2019 (COVID-19): diagnosis. 2021. Available from: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-diagnosis. Accessed date: 04 February 2021. [CrossRef] 2. Hansen KE, Caliendo AM, Arias CA, Englund JA, Hayden MK, Lee MJ, et al. Infectious diseases society of america guidelines on the diagnosis of COVID-19: serologic testing. 2020. Available from: https://www.idsociety.org/practice-guideline/covid-19-guideline-serology/. Accessed date: 21 January 2021. [CrossRef] 3. McIntosh K, Hirsch MS, Bloom A. Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention. 2021. Available from: https:// www.uptodate.com/contents/coronavirus-disease-2019-covid-19-epidemiology-virology-and-prevention. Accessed date: 21 January 2021. [CrossRef] 4. Lustig Y, Keler S, Kolodny R, Ben-Tal N, Atias-Varon D, Shlush E, et al. Potential antigenic cross-reactivity between SARS-CoV-2 and dengue viruses. Clin Infect Dis 2020
  2. ciaa1207. [CrossRef] 5. Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 2020
  3. [CrossRef] 6. Mateus J, Grifoni A, Tarke A, Sidney J, Dan JM, Burger ZC, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science 2020
  4. [CrossRef] 7. Braun J, Loyal L, Frentsch M, Wendisch D, Georg P, Kurth F, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 2020
  5. [CrossRef] 8. Ng KW, Faulkner N, Cornish GH, Rosa A, Harvey R, Hussain S, et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science 2020
  6. [CrossRef] 9. Centers for Disease Control and Prevention (CDC). Interim guidelines for COVID-19 antibody testing in clinical and public health settings. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/ lab/resources/antibody-tests-guidelines.html?deliveryName=USCDC_2067-DM29085. Accessed date: 29 January 2021. [CrossRef] 10. Bastos ML, Tavaziva G, Abidi SK, Campbell JR, Haraoui LP, Johnston JC, et al. Diagnostic accuracy of serological testss for COVID-19: systematic review and meta-analysis. BMJ 2020
  7. m2516. [CrossRef] 11. Nivedhita G, Brundha MP. Eclia Test-Review. IJFMT 2020
  8. [CrossRef] 12. Chang L, Zhao J, Guo F, Ji H, Zhang L, Jiang X, et al. Comparative evaluation and measur